CryoPort (CYRX) stock

Logistics and biostorage , market cap $813M

Logistics and biostorage

Worth $813M

$20.35

-0.61%

As of 11:18 AM ET, delayed 15+ min · Live for Pro members

Quality Score

Excellent

In its industry

#10of 90

Pharma

Checks firing

9of 14

Trending up

From 52-week high

-1.1%

under its best in a year

CYRX's Quality Score rose 2 points on Mon, Nov 9, to 15. Its price closed above its average of the last 21 days, which is rising (2 chart checks started).

See CYRX's 14 chart checksSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why CYRX is up 28% since Nov 5

Up 28% so far from Nov 5 to Nov 10.

CryoPort rose 28% so far from Nov 5 to Nov 10. 19 points of it came on Nov 6, the session after its Nov 5 results.

Sources: Price history, Nov 10, 2026; SEC filing, Nov 5, 2026

1 more reason, free with an account →3 more reasons why CYRX is up 28% since Nov 5, from its filings, with the other side, the timeline, and its peers, for Pro members.

Key facts on CYRX

Key facts on CYRX
The chart	Stronger than 98% of stocks over the last 3 months
Latest filing	8-K, Nov 5 Reported its quarterly results

1 more reason behind CYRX's 15, free with an account →6 more reasons behind CYRX's 15, for Pro members.

CYRX in the news

Fri Nov 6Cryoport Reports Third Quarter 2026 Financial Results SEC filing 4:31 PM ET · PR Newswire CYRX closed +19.0% that day.

CYRX catalysts

Coming up

After its last 4 reports it closed +11.0% on average, higher 4 of 4 times.

6 past catalysts since 2020, with sizes and sources, for Pro members.

Why CYRX scores 15

Excellentfor quality, not price, 9 of 14 chart checks firingWhat the Quality Score means

Well above its recent run. CYRX scores 15 today, against a median of 10.5 over its last 20 recorded sessions.

+9Chart checks 9 of 14 firing right now, one point each
+3Long-term trend above a rising 200-⁠day average, near its 52-⁠week high

Run-up adds
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.
Persistence adds
News adds

No effect today: Size and Dilution.

What every line is worth, and the reason behind it, on CYRX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 11:18 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when CYRX's Quality Score turns up

A free account. No card.

How CYRX ranks in Pharma

CYRX is #10 of 90 by Quality Score.

How CYRX ranks in Pharma
Rank	Stock	Checks	Quality Score
1	ABBVAbbVie	9/14	22
2	LLYEli Lilly	7/14	20
3	GMABGenmab	7/14	18
	CRMDCorMedix		Open for its score
	CRONCronos		Open for its score
	CYTKCytokinetics		Open for its score
	ELANElanco Animal Health		Open for its score
10	CYRXCryoPort	9/14	15

When does CYRX report earnings, and what happens after?

Expected to report Tue Mar 2, after the close (in 112 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What CYRX reported on Nov 5, 2026

The quarter

Sales of $50.2M, 14% more than a year ago; a loss of $0.25 a share, from $0.18.

The quarter that ended Sep 30, from the company's press release

The press release The filing on EDGAR

Where the sales came from

Where the quarter's sales came from
Line	Q3 2026	Q2 2026	Q3 2025
By product
Serviceup 18%	$28.6M57%	$28M57%	$24.3M55%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 5)

6 more lines, for Pro members.

The outlook

The outlook the company gave, by period
Measure	Figure
Full year 2026
Revenue	$197M to $199Mraised

Figures as filed (SEC filing, Nov 5)

The numbers

Market value: $813M; today
Sales: $192M; up 11.8% on the year
Free cash flow: -$18.8M; last 12 months

Sales grew 18% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 5.4% a year over 5 years.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on CYRX: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

+19.4%+2.8%+19.0%

May 4Aug 6Nov 5

Reported	When	Gap	Reaction	5 days
Nov 5, 2026After close	After close	+9.0%	+19.0%	not yet
Aug 6, 2026After close	After close	+3.5%	+2.8%	+2.9%
May 4, 2026After close	After close	+7.7%	+19.4%	+29.0%

CYRX closed higher after 4 of its last 4 reports.

All 4 reports, and CYRX's Quality Score going into each

CYRX sales and profit by year

Sales and profit by year

Sales grew in five of the last seven years, to $176M in 2025. It turned a profit in 2025 after a loss in 2024.

CYRX has 9 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on CYRX, and all 14 on every stock.Get in free →

CYRX RSI today: 65.7, above its 50-day and 200-day averages

Not scored

RSI 65.7, MACD above signal, above both averages. Not scored.13 readings

The deep dive on CYRX

What it does and how it makes money6 findingsServices made up 55% of its revenue in fiscal 2025 ($96.5M of $176M), against 52% in fiscal 2024; product sales 45%.SEC filing · Mar 5, 2026
Where it stands3 findingsFor Pro members3 findings on where CYRX stands: its cash, debt, and share count, for Pro members
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades CYRX, for Pro members

10 more findings on CYRX, each with its source, for Pro members.

CYRX insider trades

3 insiders sold $3.6M across 4 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellEdward J. Zecchini$486KChief Digital and Tech Officerat $14.47 on Jun 11, filed Jun 12

SellEdward J. ZecchiniChief Digital and Tech Officer$486Kat $14.47 on Jun 11, filed Jun 12

All 4 insider filings on CYRX from the last six months, for Pro members.

All CYRX insider trades

CYRX's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Jerrell SheltonPresident, CEO · 3 trades
Robert StefanovichChief Financial Officer · 3 trades
Robert StefanovichChief Financial Officer · 1 trade
Edward J. ZecchiniChief Digital and Tech Officer · 2 trades
Mark W. SawickiChief Scientific Officer · 2 trades
Edward J. ZecchiniChief Digital and Tech Officer · 1 trade
Ramkumar MandalamDirector · 1 trade
Ramkumar MandalamDirector · 1 trade

3 more officers and directors file at CYRX.

See insider trades by person

Which ETFs hold CYRX?

In ETFs: CYRX is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About CryoPort

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

738 employeesBrentwood, TNcryoportinc.com

What CryoPort says it competes with

“Collectively, Cryoport’s specialized expertise in providing advanced temperature-controlled supply chain solutions for the Life Sciences including, but not limited to, proprietary technologies, regulatory expertise, global infrastructure, embedded customer relationships, and a data-driven operating model create substantial competitive advantages.”

From its annual report, SEC filing · Mar 5, 2026

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on CYRX and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would move CYRX's score: 7 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayJun 12Edward J. Zecchini sold CYRX$486K at $14.47, filed Jun 12

Alerts are optional.

See CYRX's 14 chart checks

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: CYRX's Quality Score is 15 (Excellent), #10 of 90 in Pharma. Insiders sold $3.6M in the last 6 months (Form 4).

What does CYRX's Quality Score say?

CYRX scores 15 today, which Breakaway calls Excellent. It is #10 of 90 in Pharma by Quality Score, with 9 of 14 chart checks firing. Up 28% so far from Nov 5 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is CYRX's Quality Score?

CYRX scores 15 today, which Breakaway calls Excellent (15 to 19). That is #10 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CYRX's 15.

Are insiders buying CYRX?

3 insiders sold $3.6M across 4 filings in the last 6 months. No open-⁠market buys on record. The newest is Edward J. Zecchini, Chief Digital and Tech Officer, who sold $486K on Jun 11. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.